Clark SJ et al. [41] discovered that mCpmCpG methylation could have a biological function in preventing Sp1 binding, thereby contributing to the subsequent abnormal methylation of CpG islands often observed in tumor cells. The gene discussed is SP1; the disease is neoplasm.